Every two minutes, a woman dies from cervical cancer, yet this could be prevented through routine human papillomavirus (HPV) vaccinations. UNICEF’s latest report emphasizes the critical role of HPV vaccines in combating cervical cancer, especially in low- and middle-income countries where access to these life-saving vaccines remains limited.
Despite global progress, cervical cancer ranks as the fourth most common cancer among women worldwide. In 2022, it claimed approximately 350,000 lives and introduced 660,000 new cases, predominantly affecting families and communities in Sub-Saharan Africa, Central America, and South-East Asia, where the mortality rates are alarmingly high.
The predominant cause of cervical cancer, HPV, is also the world’s most frequent sexually transmitted infection. “More than 95 percent of cervical cancer cases are caused by the human papillomavirus,” the UNICEF report notes, underscoring the critical importance of preventive measures. Fortunately, vaccines can shield against up to 90% of these cases. Yet, as of 2022, “fewer than one in five girls globally have been vaccinated against HPV,” highlighting a significant gap in global health coverage.
Screening and early treatment are both viable and essential. “Routine screening tests are an effective way to detect and diagnose cervical cancer,” the report states, emphasizing that early detection often leads to a complete recovery through surgical means alone. However, in many low-income countries, less than 5% of women ever undergo screening for cervical cancer.
UNICEF is at the forefront of expanding access to HPV vaccines and cervical cancer screening and treatment services. The organization’s efforts include providing affordable vaccines and diagnostics, strengthening healthcare systems, training medical staff, and fostering community trust in vaccination programs. These initiatives aim to embed cervical cancer prevention within broader health strategies to eliminate it as a public health issue.
Challenges persist, particularly in the poorest nations, where “less than 25 percent of low-income countries have introduced the HPV vaccine into their immunization schedules,” the report mentions. UNICEF continues to generate evidence on the impact of vaccination programs to enhance their effectiveness and reduce the incidence of cervical cancer.
This report calls for enhanced support in financing and logistics to improve prevention, screening, and treatment services, especially in regions lacking adequate resources. By confronting these systemic issues, significant progress can be made in protecting the health and future of women and girls worldwide.